92
Views
13
CrossRef citations to date
0
Altmetric
Drug Profile

Treating multiple sclerosis with natalizumab

, &
Pages 1683-1692 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Annika Deiß, Isabel Brecht, Axel Haarmann & Mathias Buttmann. (2013) Treating multiple sclerosis with monoclonal antibodies: a 2013 update. Expert Review of Neurotherapeutics 13:3, pages 313-335.
Read now
Guglielmo Lucchese. (2012) A peptide talk between JC virus and the human host: from silent infection to autoimmunity. Immunopharmacology and Immunotoxicology 34:6, pages 1067-1074.
Read now

Articles from other publishers (11)

Majid Ghareghani, Amir Ghanbari, Ali Eid, Abdullah Shaito, Wael Mohamed, Stefania Mondello & Kazem Zibara. (2021) Hormones in experimental autoimmune encephalomyelitis (EAE) animal models. Translational Neuroscience 12:1, pages 164-189.
Crossref
Augusto Maria Rini, Valentina Torri Clerici, Erminia Rinaldi, Mattea Modesto, Domenico Pastore, Paolo Agostino Confalonieri & Bruno Passarella. (2020) Severe thrombocytopenia during Natalizumab therapy: A case report. Journal of the Neurological Sciences 409, pages 116587.
Crossref
Honghui Zhou, Yan Xu & Amarnath Sharma. 2019. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology 557 617 .
Fang Zhang, Guiyou Liu, Changjuan Wei, Chao Gao & Junwei Hao. (2016) Linc‐MAF‐4 regulates T h 1/T h 2 differentiation and is associated with the pathogenesis of multiple sclerosis by targeting MAF . The FASEB Journal 31:2, pages 519-525.
Crossref
Hongbing Guan, Udai P. Singh, Roshni Rao, Davit Mrelashvili, Souvik Sen, Haiping Hao, Elizabeth E. Zumbrun, Narendra P. Singh, Prakash S. Nagarkatti & Mitzi Nagarkatti. (2016) Inverse correlation of expression of microRNA-140-5p with progression of multiple sclerosis and differentiation of encephalitogenic T helper type 1 cells. Immunology 147:4, pages 488-498.
Crossref
Masami Tanaka. (2015) Natalizumab treatment in multiple sclerosis. Rinsho Shinkeigaku 55:8, pages 537-543.
Crossref
Maria Meira, Claudia Sievers, Francine Hoffmann, Maria Rasenack, Jens Kuhle, Tobias Derfuss, Ludwig Kappos & Raija L. P. Lindberg. (2014) Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4 + T Cells of Patients with Relapsing-Remitting Multiple Sclerosis . Journal of Immunology Research 2014, pages 1-11.
Crossref
Lucienne Chatenoud. 2014. The Autoimmune Diseases. The Autoimmune Diseases 1221 1245 .
Djordje MiljkovićIvan Spasojević. (2013) Multiple Sclerosis: Molecular Mechanisms and Therapeutic Opportunities. Antioxidants & Redox Signaling 19:18, pages 2286-2334.
Crossref
Honghui Zhou, Zhenhua Xu, Mary Ann Mascelli & Hugh M. Davis. 2013. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology 393 412 .
Thomas Vorup-Jensen. (2012) On the roles of polyvalent binding in immune recognition: Perspectives in the nanoscience of immunology and the immune response to nanomedicines. Advanced Drug Delivery Reviews 64:15, pages 1759-1781.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.